Skip to main content
. Author manuscript; available in PMC: 2022 Dec 8.
Published in final edited form as: Surg Oncol. 2022 Oct 4;45:101861. doi: 10.1016/j.suronc.2022.101861

Table 1.

Patient characteristics

Characteristics N=65
N (%)
. Male 31 (47.7)
. Female 34 (52.3)
Age (years)
. < 65 45 (69.2)
. ≥ 65 20 (30.8)
Race/ethnicity
. White 60 (92.3)
. Black or African American 5 (7.7)
Employment
. Employed 32 (49.2)
. Not employed 33 (50.8)
Education
. High school or equivalent or less 21 (32.3)
. More than high school or equivalent 44 (67.7)
Tumor grade
. Grade 1 9 (13.8)
. Grade 2 12 (18.5)
. Grade 3 44 (67.7)
Tumor location
. Trunk 7 (10.8)
. Extremity 58 (89.2)
Tumor histology
. Liposarcoma 9 (13.8)
. Chondrosarcoma 9 (13.8)
. Undifferentiated pleomorphic sarcoma 8 (12.3)
. Angiosarcoma 7 (10.8)
. Osteosarcoma 7 (10.8)
. Myxofibrosarcoma 6 (9.2)
. Leiomyosarcoma 5 (7.7)
. Malignant peripheral nerve sheath tumor 4 (6.2)
. Other 10 (15.4)
Distance from cancer center (miles)
. < 50 38 (58.5)
. ≥ 50 27 (41.5)
Median [IQR]
Positive Appraisals of surveillance imaginga 14.0 [7.5, 17.0]
Negative Appraisals of surveillance imaginga 3.0 [1.0, 8.0]
PROMIS Anxiety Short Form 8a (T-score) 52.3 [43.2, 59.4]
Time in surveillance (days) 385 [183, 837]

N=65; IQR, interquartile range.

a

Five patients did not complete the Appraisal Scale, thus n=60.